Literature DB >> 8857610

Evidence for the presence of receptors for pituitary adenylate cyclase-activating polypeptide in the neurohypophysis that are positively coupled to cyclic AMP formation and neurohypophyseal hormone secretion.

B Lutz-Bucher1, D Monnier, B Koch.   

Abstract

This study examines the neural lobe of the pituitary gland for the presence of receptors for pituitary adenylate cyclase-activating polypeptide (PACAP) and their possible involvement in the regulation of neurosecretion. The presence of PACAP receptors of type I was revealed in the neural lobe, as well as in anterior and intermediate lobes, by means of RT-PCR amplification using selective oligonucleotide pairs of primers. They appeared to be expressed in the tissues as a short form together with an isoform of heavier molecular weight. Activation of receptors in the presence of PACAP stimulated both formation of cyclic AMP (cAMP) and secretion of arginine vasopressin (AVP) in neural lobes, in a dose-related fashion, with half-maximum (EC50) values of 1.0 +/- 0.2 x 10(-9) M and 1.4 +/- 0.3 x 10(-8) M, respectively. Parallel with AVP, PACAP also stimulated oxytocin (OXT) output, with an EC50 value of 0.6 +/- 0.1 x 10(-8) M. In an attempt to localize receptors on cells (mainly astrocyte-like glials or pituicytes) and/or on nerve fibers of the gland, we used cultures of neural lobe cells and explants (in which nerve fibers undergo degeneration), as well as isolated nerve endings. In both cells and nerve terminals, PACAP enhanced accumulation of cAMP, while it triggered AVP secretion from the latter. The stimulatory effect of PACAP on both AVP and OXT release was mimicked by dbcAMP and blocked by H89, an inhibitor of cAMP-dependent protein kinase. We conclude that in the neural lobe, PACAP receptors are localized on both nerve terminals and pituicytes, which participate in the modulation of secretion of neurohypophyseal hormones in an interactive way and mainly through the cAMP signalling route.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8857610     DOI: 10.1159/000127113

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  11 in total

Review 1.  Chemical modification of class II G protein-coupled receptor ligands: frontiers in the development of peptide analogs as neuroendocrine pharmacological therapies.

Authors:  Megan C Chapter; Caitlin M White; Angela DeRidder; Wayne Chadwick; Bronwen Martin; Stuart Maudsley
Journal:  Pharmacol Ther       Date:  2009-08-15       Impact factor: 12.310

2.  Peptidergic mechanisms of hyperthermia-evoked convulsions in rats in early postnatal ontogenesis.

Authors:  N E Chepurnova; A A Ponomarenko; S A Chepurnov
Journal:  Neurosci Behav Physiol       Date:  2002 Sep-Oct

Review 3.  Class II G protein-coupled receptors and their ligands in neuronal function and protection.

Authors:  Bronwen Martin; Rakel Lopez de Maturana; Randall Brenneman; Tom Walent; Mark P Mattson; Stuart Maudsley
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

Review 4.  The PACAP Paradox: Dynamic and Surprisingly Pleiotropic Actions in the Central Regulation of Energy Homeostasis.

Authors:  Nikki Le; Sarah Sayers; Veronica Mata-Pacheco; Edward J Wagner
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-01       Impact factor: 6.055

5.  The pituitary adenylate cyclase-activating polypeptide is a physiological inhibitor of platelet activation.

Authors:  Kathleen Freson; Hitoshi Hashimoto; Chantal Thys; Christine Wittevrongel; Sophie Danloy; Yoshiko Morita; Norihito Shintani; Yoshiaki Tomiyama; Jos Vermylen; Marc F Hoylaerts; Akemichi Baba; Chris Van Geet
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

Review 6.  PACAP is implicated in the stress axes.

Authors:  Hitoshi Hashimoto; Norihito Shintani; Mamoru Tanida; Atsuko Hayata; Ryota Hashimoto; Akemichi Baba
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

Review 7.  G protein-coupled receptors in the hypothalamic paraventricular and supraoptic nuclei--serpentine gateways to neuroendocrine homeostasis.

Authors:  Georgina G J Hazell; Charles C Hindmarch; George R Pope; James A Roper; Stafford L Lightman; David Murphy; Anne-Marie O'Carroll; Stephen J Lolait
Journal:  Front Neuroendocrinol       Date:  2011-07-23       Impact factor: 8.606

8.  Effect of short term diet restriction on gene expression in the bovine hypothalamus using next generation RNA sequencing technology.

Authors:  Daragh Matthews; Michael G Diskin; David A Kenny; Christopher J Creevey; Kate Keogh; Sinead M Waters
Journal:  BMC Genomics       Date:  2017-11-09       Impact factor: 3.969

Review 9.  PACAP38 and PAC1 receptor blockade: a new target for headache?

Authors:  Eloisa Rubio-Beltrán; Edvige Correnti; Marie Deen; Katharina Kamm; Tim Kelderman; Laura Papetti; Simone Vigneri; Antoinette MaassenVanDenBrink; Lars Edvinsson
Journal:  J Headache Pain       Date:  2018-08-07       Impact factor: 7.277

Review 10.  Adaptive Changes in the Central Control of Energy Homeostasis Occur in Response to Variations in Energy Status.

Authors:  Cassandra Gastelum; Lynnea Perez; Jennifer Hernandez; Nikki Le; Isabella Vahrson; Sarah Sayers; Edward J Wagner
Journal:  Int J Mol Sci       Date:  2021-03-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.